Literature DB >> 8647107

Structural studies of the O-specific polysaccharide of Hafnia alvei strain 1209 lipopolysaccharide.

T Niedziela1, C Petersson, A Helander, W Jachymek, L Kenne, C Lugowski.   

Abstract

The structure of the O-specific side chains of the Hafnia alvei strain 1209 lipopolysaccharide has been investigated. Methylation analysis and 1H-NMR and 13C-NMR spectroscopy were the principal methods used. It is concluded that the polysaccharide is composed of pentasaccharide repeating units that have the following structure: -->3)-beta-D-Galp-(1-->4)-alpha-D-Glcp-(1-->4)-beta-D-GlepA-(1--> 3)-beta-D-GalpNAc-(1 --> 4 increases 1 alpha-L-Rhap The relative intensity of the signals from the terminal repeating unit in the 1H-NMR spectrum, the amount of 2,3,6-tri-O-methylgalactose in the methylation analysis, and the matrix-assisted laser-desorption ionisation time-of-flight (MALDI-TOF) mass spectrum of the O-polysaccharide indicated that the structure is also the biological repeating unit and that the O-chains mainly consisted of 8-11 repeating units and, on average, ten repeating units.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647107     DOI: 10.1111/j.1432-1033.1996.0635p.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Structural analysis of the lipid A isolated from Hafnia alvei 32 and PCM 1192 lipopolysaccharides.

Authors:  Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Lennart Kenne; Czeslaw Lugowski
Journal:  J Lipid Res       Date:  2009-08-25       Impact factor: 5.922

2.  NMR study of the O-specific polysaccharide and the core oligosaccharide from the lipopolysaccharide produced by Plesiomonas shigelloides O24:H8 (strain CNCTC 92/89).

Authors:  Lena C E Lundqvist; Marta Kaszowska; Corine Sandström
Journal:  Molecules       Date:  2015-04-01       Impact factor: 4.411

3.  Core oligosaccharide of Plesiomonas shigelloides PCM 2231 (Serotype O17) lipopolysaccharide--structural and serological analysis.

Authors:  Anna Maciejewska; Jolanta Lukasiewicz; Marta Kaszowska; Aleksandra Man-Kupisinska; Wojciech Jachymek; Czeslaw Lugowski
Journal:  Mar Drugs       Date:  2013-02-06       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.